InvestorsHub Logo
Followers 3156
Posts 961111
Boards Moderated 205
Alias Born 09/04/2000

Re: Viewmont post# 4943

Saturday, 09/19/2020 10:30:38 PM

Saturday, September 19, 2020 10:30:38 PM

Post# of 13317
$MRNA TARGET $95
3 Moderna Analyst Takes On The Coronavirus Vaccine Developer's Pipeline
2020 Sep 18, 12:35pm | 4 min read
Coronavirus vaccine developer Moderna Inc (NASDAQ: MRNA) held a virtual R&D event Thursday, showcasing its portfolio and key therapeutic areas. The Moderna Analysts: Chardan analyst Geulah Livshits has a Buy rating on Moderna with a $95 price target. SVB Leerink analyst Mani...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRNA News